Drug General Information
Drug ID	D07PRC
Former ID	DIB007050
Drug Name	BAL-30072
Drug Type	Small molecular drug
Indication	Bacterial infections [ICD9: 001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104; ICD10:A00-B99]		Phase 1	[549110]
Company	Basilea Pharmaceutica International Ltd
Structure		Download 2D MOL 3D MOL
Formula	C16H18N6O10S2
Canonical SMILES	OS(=O)(=O)ON1C(C)(C)[C@@H](C1=O)NC(=O)/C(=N\OCc1cc(=O)c<br />(cn1O)O)/c1csc(n1)N
PubChem Compound ID	52942440
Target and Pathway
Target(s)	Bacterial penicillin binding protein	Target Info	Inhibitor	[530802]
References
Ref 549110	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800032341)
Ref 530802	In vitro properties of BAL30072, a novel siderophore sulfactam with activity against multiresistant gram-negative bacilli. Antimicrob Agents Chemother. 2010 Jun;54(6):2291-302.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.